Literature DB >> 1184950

Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology.

M C Green, L D Shultz.   

Abstract

A new recessive mutation, motheaten (me), is on chromosome 6, 21.9 +/- 4.3 recombination units distal to white (Miwh). Mice homozygous for the new mutation have neutrophilic lesions of the skin beginning as early as day 1, and pneumonitis with many macrophages in the alveoli as early as day 3. They suffer high mortality from birth onward and none has survived longer than 8 weeks. The lymph nodes may be enlarged, but the thymus, Reyer's patches, and lymphatic tissue of the spleen are much reduced in size. Lymph nodes, spleen, and Peyer's patches lack lymphatic nodules. The lymph nodes and spleen contain many plasma cells. There are increased numbers of neutrophils and monocytes in the peripheral blood, and increased numbers of neutrophils in bone marrow at the expense of red cell precursors. Hematopoietic tissue in the spleen is increased and appears more active than normal. Motheaten mice appear to have an immune deficiency beginning very shortly after birth.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1184950     DOI: 10.1093/oxfordjournals.jhered.a108625

Source DB:  PubMed          Journal:  J Hered        ISSN: 0022-1503            Impact factor:   2.645


  67 in total

Review 1.  B cell inhibitory receptors and autoimmunity.

Authors:  Nicholas R Pritchard; Kenneth G C Smith
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

Review 2.  Mouse chromosome 6.

Authors:  R W Elliott; K J Moore
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

3.  Murine "viable motheaten" mutation reveals a gene critical to the development of both B and T lymphocytes.

Authors:  C L Sidman; J D Marshall; R D Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

Review 4.  The Fas signaling connection between autoimmunity and embryonic lethality.

Authors:  H C Hsu; Y Matsuki; H G Zhang; T Zhou; J D Mountz
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

5.  Targeted loss of SHP1 in murine thymocytes dampens TCR signaling late in selection.

Authors:  Ryan J Martinez; Anna B Morris; Dennis K Neeld; Brian D Evavold
Journal:  Eur J Immunol       Date:  2016-09       Impact factor: 5.532

Review 6.  Tyrosine phosphatase SHP-1 in allergic and anaphylactic inflammation.

Authors:  Zhou Zhu; Sun Young Oh; You Sook Cho; Li Zhang; Yoon-Keun Kim; Tao Zheng
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

Review 7.  Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.

Authors:  Joseph J Sabatino; Kristen M Rosenthal; Brian D Evavold
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-11       Impact factor: 4.147

8.  The control of reactive oxygen species production by SHP-1 in oligodendrocytes.

Authors:  Ross C Gruber; Daria LaRocca; Scott B Minchenberg; George P Christophi; Chad A Hudson; Alex K Ray; Bridget Shafit-Zagardo; Paul T Massa
Journal:  Glia       Date:  2015-04-27       Impact factor: 7.452

Review 9.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

10.  Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice.

Authors:  Clare L Abram; Gray L Roberge; Lily I Pao; Benjamin G Neel; Clifford A Lowell
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.